Detalles de la búsqueda
1.
Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study.
Am Heart J
; 259: 30-41, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642226
2.
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.
N Engl J Med
; 380(8): 720-728, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30786186
3.
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre-specified subgroup analysis of the randomized CASSINI study.
Cancer Med
; 9(17): 6196-6204, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663379
4.
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial.
TH Open
; 4(2): e107-e112, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32462111
5.
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
Clin Ther
; 29(10): 2215-21, 2007 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18042477
6.
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis.
Urology
; 71(1): 17-22, 2008 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18242357
7.
A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis.
Curr Med Res Opin
; 23(11): 2637-45, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17880755
Resultados
1 -
7
de 7
1
Próxima >
>>